Circular splicing has already been described on nuclear pre-mRNA for certain splice sites far apart in the multi exonic ETS-1 gene and in the single 1.2 kb exon of the Sry locus. To date, it is unclear how splice site juxtaposition occurs in normal and circular splicing. The splice site selection of an internal exon is likely to involve pairing between splice sites across that exon. Based on this, we predict that, albeit at low frequency, internal exons yield circular RNA by splicing as an error-prone mechanism of exon juxtaposition or, perhaps more interestingly, as a regulated mechanism on alternative exons. To address this question, the circular exon formation was analysed at three ETS-1 internal exons (one alternative spliced exon and two constitutive), in human cell line and blood cell samples. Here, we show by RT-PCR and sequencing that exon circular splicing occurs at the three individual exons that we examined. RNase protection experiments suggest that there is no correlation between exon circle expression and exon skipping.
INTRODUCTION
The c-ets-1 proto-oncogene belongs to the Ets gene family which encodes DNA-binding transcription factor proteins. Most Ets family members act either alone or in synergy with various cofactors to regulate numerous viral and cellular promoters (1) . The human c-ets-1 locus encodes a major 6.4 kb transcript and alternatively spliced transcripts (2, 3) . In addition, we previously detected by PCR a peculiar splicing reaction which leads to additional transcripts. Indeed, we showed that the donor splice site of two exons of the human ets-1 pre-mRNA can splice to the acceptor splice site of an upstream exon (4, 5) . This reaction, originally called mis-splicing (now called circular splicing) yields circular RNA molecules containing only exon sequences which are localised in the cytoplasm of cells. Circular transcript formation has also been described, for the Sry transcript in mouse testis, due to splice sites used in a 3′→5′ direction (6) . In addition, it is likely that the scrambled exons described in the DCC gene (deleted in colorectal carcinomas) (7) , also correspond to circular transcript formation but this has not been proved. Due to loss of ORF or the absence of ribosome attachment, these circular RNAs are likely to be non-coding. However, eukaryotic ribosomes can initiate translation on circular RNAs but only if the RNAs contain internal ribosome entry site elements (8) . The biological function of these natural circular RNAs is to date unknown but they may act as functional RNA as suggested for non-coding RNAs like XIST and H19 (9, 10) or the 3′ untranslated region of some mRNA (11) .
To date, it is unclear how splice site juxtaposition occurs in normal and circular splicing and studies of circular splicing may help to elucidate the mechanism of normal exon juxtaposition. ETS-1 circular splicing occurs at splice sites close to large introns (5) . This suggest a leaky mechanism for the orderliness in splicing which occurs more frequently for certain splice sites. It is also noteworthy that, in addition to the proximity of large introns, the ETS-1 circular splicing occurs efficiently with an alternative exon. Similarly, most of the introns of the DCC gene which also yields scrambled exons are large and some exons are also alternatively spliced (12) . Concerning Sry, the mono-exonic structure of the gene and the inverted repeats in both ends of the transcript are probably involved in the circular transcript formation (6) . The suggested mechanism is similar to the intramolecular base pairing described in the intron of the gene that encodes the 40S ribosomal subunit, RP51. The intron complementarity has been shown to influence positively the splice site selection and the splicing efficiency (13) . Recently, in vitro spliceosome formation on a circular yeast pre-mRNA has been described and the products of the resulting splicing reaction are the lariat-shaped intron and a mature circular mRNA (14) . On the other hand, autocatalytic introns may also yield in vitro exon circle RNA with an appropriate substrate in which the splice sites flanking a group I or group II intron are inserted at both ends of an exon (15, 16) . In this case, the RNA structure of the autocatalytic intron is obviously involved in the splice site juxtaposition for circular splicing.
Except for the intronless Sry gene, circular splicing involves an accurate selection of both the splice sites and the exon, as in normal mRNA maturation. The splice site selection, in particular of an internal exon, is likely to involve pairing between splices sites across the exon. Indeed, the internal exon which is rather small (17, 18) , seems to be the unit for splice site recognition (19) , but the mechanism that ensures exon juxtaposition across the intron is unclear and this problem is even more complex in the case of transcripts containing alternative exons. Based on this, we predict that internal exons probably yield exon circles at a low frequency as a result of an error-prone mechanism of exon juxtaposition.
Here, we test the prediction that splicing may occur with the donor and acceptor splice sites from an exon, producing excised exon circles and ask whether this reaction may participate in an alternative splicing mechanism by deleting exons from nuclear pre-mRNA or, alternatively, by splicing of an alternative exon in a lariat-shaped intron. The ETS-1 locus is a good model to answer these questions because two exons skip during mRNA maturation at different frequencies (3, 20) and the circular splicing involving multiple exons is already known (4) . In this present work, we show that sets of oligoprimers in opposite directions in an exon can amplify, products from poly(A) -RNA by RT-PCR and that the sequence of the PCR products confirms exon circular splicing. RNase protection experiments have been performed to quantify the level of exon circle expression. Although the conventional ETS-1 RNA has the potential to fully protect the antisense probe from the circular RNA, probably via a loop-out artefact, the expression data from the exon which skips at high frequency in this cell line shows that the signal corresponding to fully protected probe is too low, relative to the alternative spliced transcript, to correspond to a secondary product of the alternative splicing of this exon or splicing event occurring in the excised lariat containing the alternative exon. The existence of the exon circle for constitutive and alternative exons and RNase protection experiments suggest that the exon circle splicing is independent of alternative splicing processes.
MATERIALS AND METHODS

PCR amplification, cloning and sequencing
Total RNA was prepared from cell lines using the guanidinium thiocyanate-caesium chloride method as previously described (28) . Poly(A) + and poly(A) -RNA was isolated from total RNA using double passage over oligo(dT)-cellulose chromatography. Poly(A) -RNA was separated by sedimentation through a 10-20% sucrose linear gradient in 5 mM Tris-HCl pH 7.4, 2.5 mM EDTA, 0.5% SDS to collect the top fractions containing RNA smaller in size than 18S as determined by agarose gel electrophoresis. This RNA (1.5 µg) was reverse transcribed in 10 µl containing 200 ng sense primer, 1 µg BSA, 1.5 mM each dNTP, 50 mM Tris-HCl pH 8.3, 75 mM KCl, 10 mM DTT, 3 mM MgCl 2 , 100 U MuMLV reverse transcriptase (Gibco-BRL) for 1 h at 37_C. Reverse transcription mixture was included in a final volume (100 µl) of PCR reaction containing 100 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 1 U Taq polymerase (Stratagene) and 200 ng of antisense primer. Amplification was performed by 30 cycles; 92_C (1 min), 60_C (1 min) and 72_C (1 min) in a techne PHC-2 thermocycler. Aliquots of the PCR reaction (10 µl) were electrophoresed on a 2% agarose-TBE gel. The sequences of the primers are indicated in Figure 1 by < and > signs. The amplification products were cloned into the EcoRV site of pBluescript II SKvector (Stratagene) and sequenced by the dideoxynucleotide method.
RNase protection assay
PCR products, as shown in Figure 1c , were inserted into the EcoRV site of pBluescript SK-vector. The clones which by sequencing did not show any point mutations were chosen to perform the RNase protection experiments which were performed, as previously described (5) , using total RNA from human CEM cell line. The plasmids were linearized with a restriction enzyme and used as a template for T3 or T7 RNA polymerase (Stratagene). Total RNA (50 µg) was hybridized to 10 5 c.p.m. of 32 P-labelled uridine probe overnight at 45_C in 20 µl of hybridization buffer (80% formamide, 400 mM NaCl, 40 mM PIPES pH 6.4, 1 mM EDTA). After RNase A and T1 digestion (10 µg/ml and 130 U/ml, respectively) in 300 µl of digestion buffer (10 mM Tris pH 7.6, 5 mM EDTA, 0.3 M NaAc pH 7.0) at 37_C for 30 min, purified and precipitated samples were analysed by electrophoresis on a 6% acrylamide-8 M urea gel and exposed to Cronex X-ray film in the presence of intensifying screens for 2 days.
RESULTS
To investigate circular exon formation, we designed oligonucleotide primers (see Fig. 1a and b) (Fig. 1c) . Control experiments minus reverse transcriptase do not reveal these amplified products (data not shown). The sizes of the PCR products were as expected for circular splicing of these exons according to the primer position and the exon size. To confirm this observation, the PCR products were cloned and sequenced ( Fig. 1d and e). The sequences confirm the correct amplification of the primers on the ETS-1 transcripts and reveal the joining of exon ends at the splice site used in the normal maturation for each of the exons examined. For example, the sequence of the 62 bp amplified product shows that the 3′ nucleotides of the a1 exon, i.e. nAAAG, are followed by the 5′ nucleotides of the same exon, i.e. ATATn ( Fig. 1d and e) . The splice site sequences of each exon are already described (3) and are indicated in Figure 1b . The expression of this RNA was not restricted to the CEM cells. Indeed, these RT-PCR products were also observed with poly(A) -RNA from a range of cells which expressed high levels of ETS-1 transcript like Jurkat, HSB2 and MDA cell lines but also from human blood cell samples (data not shown).
RNase protection experiments with 32 P-labelled uridine antisense riboprobes covering the circular splicing junctions were performed in order to determine the expression level of circular exons. Unfortunately, full protected probe was observed after hybridization to an in vitro synthesised conventional sense RNA (data not shown) as already described for S1 nuclease mapping (21) . However, the RNase protection experiments from the alternative d exon is informative. From total RNA of CEM cells, d exon circle expression could be estimated as a maximum limit of expression from the RNase protection experiments. Indeed, using the conventional 6.4 kb ETS-1 transcript as an internal control in the RNase protection experiments, the signal corresponding to full protected probe will correspond to the exon circle expression and potential loop-out artefact with the linear transcript. Figure 2 shows the RNase protection experiments of d exon from total RNA of CEM cells and, as expected, both a 105 nt protected fragment corresponding to the fully protected probe and the 67 nt protected fragment from conventional ETS1 mRNA are observed. Similarly, the RNase protection experiments from the a1 and c exons revealed the expected protection products through the circular spliced junction and protection products corresponding to the linear transcript (Fig. 3) . The 62 and 63 nt protected fragments corresponding to a1 and c exons, respectively, as circular RNA, are observed 1 and 2) , the negative control experiment using 50 µg of tRNA (lane 3), the experiments using 50 µg of total RNA from CEM cell (lane 4) and a size marker (lane 5) were loaded onto 6% acrylamide gels. The arrow indicates the circular exon protected fragment.
as a faint band (Fig. 2) . Both experiments reveal smaller protected fragments around 40 nt, which correspond to protection of one end of the exons probably by the ETS1 mRNA. To quantify the signals, the acrylamide gels were transferred to Whatman paper and the circular and the linear transcript protected products were 32 P counted. The length, the uridine percentage of the protection band the surrounding background were taken into account when estimating the expression level. These data show that the protected bands which correspond to the exon circles and probable protections from the conventional RNA via a loop-out artefact are ∼1% of the total ETS1 expression.
DISCUSSION
In this paper we have shown that sets of oligoprimers oriented in opposite directions in an exon are able to amplify products from poly(A) -RNA by RT-PCR. These products are likely to have a circular exon structure, indeed in addition to the sequence data showing the joining of exon ends, these RNAs are contained in the top fractions from an RNA sucrose gradient loaded with poly(A) -RNA. Spliceosome and splicing reaction are involved in the formation of these molecules as shown by the accurate selection and use of the splice sites. The splice sites of these exons do not reveal any difference (Fig. 1) with the splice site consensus sequence (22) that could explain the exon circle formation. Furthermore, the absence of 3′ and 5′ ends of the circular molecule may participate directly in the stability of these RNAs and, consequently, to their presence in the cell. The circular transcripts, involving multiple exons that we have previously identified (4), have been detected in the same poly(A) -RNA fraction. Direct evidence of the circular structure of the molecule, produced by splicing of the acceptor sites of the d exon and the a1 exon (4), has been obtained by Northern blot experiments on acrylamide gels (unpublished data). Because of the small size of these exon circles and the low expression level, they are difficult to visualise by Northern blot. From the present work, it is not possible to exclude intermolecular splicing, however, to explain the small size and the absence of poly(A) tail of a linear molecule containing two similar exons in tandem, additional events like multiple aberrant splicing has to be imagined. To our knowledge, these data are the first evidence of exon circles in cells from nuclear pre-mRNA. Circular splicing of Sry in adult mouse testis, where no function has been determined, differs from the ETS-1 exon circle formation. In this case the exon is 1231 bp in length and the splice sites of this intronless gene are not selected in the genital ridge, its critical site of action (6) . Recently, in vitro circular exon formation has been obtained from circular yeast pre-mRNA, suggesting that free 5′ and/or 3′ ends of a pre-mRNA are not obligatory for a splicing reaction to occur (14) . The group I and group II exon circle has been obtained in vitro using modified transcripts which contain elements of the catalytic intron in both sides of an exon (15, 16) . Another stable circular molecule has been described in T cells but this molecule corresponds to an intron as a lariat structure (23) .
We have shown, by RNase protection experiments, that the fully protected probe for the three circular exons correspond to ∼1% of the total protected signal in CEM cells. The expression of the circle exons are probably smaller than this value, because of a possible protection by the conventional ETS-1 mRNA, via a loop-out artefact as already described (21) . ETS-1 transcripts resulting from alternative splicing of the d exon have been described (20) and it has been noted that the cell lines in culture contain abundant d exon skipping, far above 1% (2) . The CEM cell line is one of the cell lines studied (Collyn-d'Hooghe, personal communication). No alternative splicing of the c and a1 exons has been observed during this study (2) . So, there seems to be no correlation between the exon circle formation and the alternative splicing of exons, because we observed exon circle formation for constitutive exons and we observed similar exon circle expression for both types of exons. Then, the circular exon formation does not occur concomitant to an exon skipping during the mRNA maturation and this also excludes the possibility that exon circle formation corresponds to splicing occurring on circular substrates as, for example, a lariat shaped intron containing an alternative exon. Indeed, the d exon skipping during the mRNA maturation forms a lariat-shaped intron which contains an intact d exon. We might think that this secondary product could be the target of circular splicing as observed in vitro with a circular yeast pre-mRNA (14) . In addition, the immature pre-mRNA that undergoes circular exon formation from a constitutive exon is likely to be degraded because there is no conventional transcript in which the exon is excluded in the cells.
Circular exon formation is interesting in regard to the two steps in spliceosome assembly; the splice site selection and the exon juxtaposition. The splice site selection for exon circle formation is correct as shown by the sequence data and we may think that the selection probably occurs in the pre-mRNA across an exon as described in the exon definition model (19) . The components involved in the exon definition model are not yet fully characterised but the spliceosome particles containing U1 snRNP, U2AF and a number of distinct protein factors which bind with some degree of selectivity to the polypyrimidine tract and/or the AG dinucleotide are probably involved in the exon-bridging interactions (19, 24) . The exon definition model does not offer a solution for the following step of exon juxtaposition across introns. It has been proposed that interactions between SR proteins bound to one exon with the SR proteins bound to an adjoining exon could participate in exon juxtaposition. The hnRNPs proteins are also potential components of this step (19) . The exon circle formation in vivo shows that a correctly recognised exon may at low frequency undergo incorrect juxtaposition by joining and splicing both splice sites of the exon.
It is noteworthy that the exon circle from ETS-1 exons are observed by RT-PCR from different cell lines and normal human blood sample. It can be concluded that splice site recognition through the exon (19) must include a mechanism for avoiding or reducing splice site juxtaposition yielding exon circle formation. It is at present unclear to what extent the concentration of trans-acting factors, like SR proteins and hnRNP proteins, may influence the level of circular exon formation as described for alternative splicing (25) (26) (27) . To date, despite the absence of this observation for other genes and other exons, it is likely that during intron excision, many, if not all, internal exons may be circularly spliced at a relatively low frequency by the incorrect juxtaposition of splice sites. Further studies of the process of circular exon production may yield insights into the process of exon juxtaposition during maturation of pre-mRNA in eukaryotic cells.
In conclusion, these results show that, albeit at low level, all examined exons undergo circular splicing. The nuclear spliceosomal process is error-prone and joins exon splice sites out of their functional order for protein synthesis. A consequence of circular exon formation is the loss of mRNA. However, given the accumulating evidence of the existence of a variety of functional RNA molecules (9-11), a functional role for circular exonic RNA molecules cannot be excluded.
